Drug Profile
Mycobacterium vaccae vaccine - AnHui Longcom Biologic Pharmacy
Alternative Names: VaccaeLatest Information Update: 02 Jun 2016
Price :
$50
*
At a glance
- Originator AnHui Longcom Biologic Pharmacy
- Class Antituberculars; Tuberculosis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Tuberculosis
Most Recent Events
- 31 May 2016 Anhui Longcom Biologic Pharmacy completes a phase III trial for Tuberculosis in China prior to May 2016 (ChiCTR-PRC13003741)
- 31 Jan 2001 Launched for Tuberculosis in China (IM)
- 31 Jan 2001 Registered for Tuberculosis in China (IM)